Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Kaiser Permanente Ventures

BioCentury | Nov 2, 2019
Finance

American Cancer Society’s BrightEdge venture fund hoping to do well by doing good

How BrightEdge is leveraging the American Cancer Society brand to invest alongside top-tier VCs
BioCentury | Jul 24, 2019
Financial News

New investors bring key connections to Freenome’s machine learning diagnostics

The multi-analyte cancer screening company sought relationships as it plans a pivotal study
BioCentury | Sep 12, 2016
Financial News

Chrono Therapeutics completes venture financing

BioCentury | Sep 8, 2016
Financial News

Chrono raises $47.6M in series B

BioCentury | Jul 15, 2013
Regulation

Coding for utility

Medicare clinical utility demands killing model for molecular diagnostic LDTs
BioCentury | Jun 3, 2013
Company News

Predictive Biosciences diagnostic news

BioCentury | Jul 23, 2012
Financial News

Agile Therapeutics completes venture financing

BioCentury | Jul 20, 2012
Financial News

Agile adds $40M in series C

Items per page:
1 - 10 of 31